Feeling like you’re facing
cancer alone…

Omico works with patient advocacy groups to provide new treatment options and tangible support for individuals and families affected by rare, difficult-to-treat, advanced and early-onset cancers. We’re also working to transform tomorrow’s healthcare system.

Omico is a national government-backed network of researchers, clinicians, industry members and oncology drug developers that’s looking to partner with advocacy groups to drive new hope and possibilities for Australians with cancer.

We’re working with government and industry to increase support and funding for precision medicine, so we can match those with rare, difficult-to-treat, advanced and early-onset cancers to clinical trials of innovative new therapies.

• Help improve patient access to genomic screening and molecular profiling
• Help bring new treatments to Australia
• Support our research and trials
• Support a particular cohort or subtrial
• Provide support for patients and families
• Advocate for ongoing funding and support
• Co-promote our programs
• And more

Australian Rare Cancer Portal

The Australian Rare Cancer (ARC) Portal is an online referral service that aims to improve outcomes and access to research for Australians diagnosed with rare cancer.

Working together with your cancer specialist, the ARC Portal offers expert clinical advice, particularly for Australians who live far away from major metropolitan centres where cancer centres may not be available.